In patients with AD, there is a deficiency in the levels of the neurotransmitters acetylcholine (ACh) and butyrylcholine (BCh) and an overexpression of the enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) [7,8]. This evidence concerns the gene ACHE and Alzheimer disease.